Cigna Group $CI Shares Sold by Premier Path Wealth Partners LLC

Premier Path Wealth Partners LLC cut its stake in shares of Cigna Group (NYSE:CI) by 11.5% in the second quarter, according to its most recent disclosure with the SEC. The firm owned 1,736 shares of the health services provider’s stock after selling 225 shares during the period. Premier Path Wealth Partners LLC’s holdings in Cigna Group were worth $574,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the stock. Financial Network Wealth Advisors LLC raised its position in Cigna Group by 26.8% during the first quarter. Financial Network Wealth Advisors LLC now owns 161 shares of the health services provider’s stock worth $53,000 after acquiring an additional 34 shares during the period. Central Pacific Bank Trust Division raised its position in shares of Cigna Group by 1.0% in the second quarter. Central Pacific Bank Trust Division now owns 3,440 shares of the health services provider’s stock valued at $1,137,000 after buying an additional 35 shares during the last quarter. Pure Portfolios Holdings LLC raised its position in shares of Cigna Group by 4.9% in the first quarter. Pure Portfolios Holdings LLC now owns 773 shares of the health services provider’s stock valued at $254,000 after buying an additional 36 shares during the last quarter. Legacy Financial Advisors Inc. raised its position in shares of Cigna Group by 2.9% in the first quarter. Legacy Financial Advisors Inc. now owns 1,400 shares of the health services provider’s stock valued at $461,000 after buying an additional 39 shares during the last quarter. Finally, Samalin Investment Counsel LLC raised its position in shares of Cigna Group by 2.2% in the first quarter. Samalin Investment Counsel LLC now owns 1,792 shares of the health services provider’s stock valued at $590,000 after buying an additional 39 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. Wells Fargo & Company upped their price objective on shares of Cigna Group from $340.00 to $354.00 and gave the company an “equal weight” rating in a report on Tuesday, October 7th. Robert W. Baird set a $372.00 price objective on shares of Cigna Group in a report on Thursday, August 14th. Wolfe Research dropped their price objective on shares of Cigna Group from $345.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, October 15th. Weiss Ratings reissued a “hold (c+)” rating on shares of Cigna Group in a report on Wednesday, October 8th. Finally, Cantor Fitzgerald reissued an “overweight” rating and issued a $365.00 price objective on shares of Cigna Group in a report on Tuesday, August 26th. Two research analysts have rated the stock with a Strong Buy rating, sixteen have given a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $369.89.

Insider Buying and Selling at Cigna Group

In related news, insider Nicole S. Jones sold 28,526 shares of the business’s stock in a transaction dated Friday, August 15th. The shares were sold at an average price of $300.00, for a total value of $8,557,800.00. Following the completion of the transaction, the insider owned 25,648 shares of the company’s stock, valued at approximately $7,694,400. The trade was a 52.66% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Brian C. Evanko sold 5,368 shares of Cigna Group stock in a transaction dated Friday, October 3rd. The shares were sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the sale, the insider owned 51,182 shares of the company’s stock, valued at $15,354,600. This trade represents a 9.49% decrease in their position. The SEC filing for this sale provides additional information. 0.70% of the stock is currently owned by insiders.

Cigna Group Stock Down 17.4%

CI stock opened at $247.11 on Friday. The company’s 50 day moving average is $298.38 and its two-hundred day moving average is $306.70. The stock has a market cap of $65.96 billion, a P/E ratio of 13.49, a PEG ratio of 0.88 and a beta of 0.45. Cigna Group has a twelve month low of $245.61 and a twelve month high of $350.00. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, October 30th. The health services provider reported $7.83 earnings per share for the quarter, beating analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm had revenue of $69.57 billion for the quarter, compared to analyst estimates of $66.40 billion. During the same period last year, the firm posted $7.51 EPS. Cigna Group’s quarterly revenue was up 9.5% on a year-over-year basis. Cigna Group has set its FY 2025 guidance at 29.600- EPS. Research analysts expect that Cigna Group will post 29.77 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th will be given a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Thursday, December 4th. Cigna Group’s payout ratio is presently 32.97%.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.